Clinical Trials Directory

Trials / Completed

CompletedNCT05926089

Acute Phase Reactant in Non-COVID-19 Bacterial Pneumonia

Acute Phase Reactant in Non-COVID-19 Community Acquired Pneumonia

Status
Completed
Phase
Study type
Observational
Enrollment
51 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study is a cross-sectional study, was conducted at Chest department of Kasr Al-ainy Hospital, Cairo university during the period between October 2020 and April 2021. The aim of the work was to evaluate levels of acute phase reactants(APR) in Non-COVID-19 bacterial pneumonia, and to correlate between levels of APR and the disease severity.

Detailed description

51 patients were included in our study, diagnosed as Non-COVID pneumonia Inclusion criteria: 1. PCR(polymerase chain reaction) negative for COVID. 2. All patients of both sexes with pneumonia . Exclusion criteria: 1. Non pulmonary infections. 2. Post surgery patients. 3. Renal patients. 4. hepatic patients. 5. Cardiac patients. 6. Recent pulmonary embolism. Methodology in details: All patients were subjected to: 1. Full history with emphasis on: * Epidemiological features (age, gender). * Risk factors (smoking, DM). * Clinical presentation (cough, Fever and duration of illness). 2. Clinical examination (local chest examination). 3. Laboratory investigations: venous blood samples were taken to measure APR

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBlood samplingblood sampling to measure APR

Timeline

Start date
2020-10-01
Primary completion
2021-04-30
Completion
2021-05-30
First posted
2023-07-03
Last updated
2023-07-14

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05926089. Inclusion in this directory is not an endorsement.